2026. DEVELOPMENT OF ANTITUMOR DENDRITIC CELL VACCINES WITH ALDH1A2 INHIBITORS TO OVERCOME IMMUNE SUPPRESSION. Review Journal of Neurological & Medical Sciences Review. 4, 3 (Jun. 2026), 659–676. DOI:https://doi.org/10.63075/1dpm7056.